Fixed drug eruption due to pipemidic acid

Area of Science:

• Dermatology
• Pharmacology

Background:

• Fixed drug eruption (FDE) is a unique cutaneous adverse drug reaction characterized by recurrent, well-demarcated lesions at previously affected sites upon re-exposure to the causative agent.
• Pipemidic acid, a quinolone antibiotic, has been implicated in various adverse drug reactions, though FDE is less commonly reported.

Observation:

• A 71-year-old female patient presented with a history suggestive of FDE.
• Diagnostic rechallenge with pipemidic acid confirmed the diagnosis by eliciting characteristic lesions.
• Notably, rechallenge with nalidixic acid, a structural analogue of pipemidic acid, did not provoke any adverse skin reactions.

Findings:

• The case demonstrates a specific hypersensitivity reaction to pipemidic acid, consistent with FDE.
• The absence of a reaction to nalidixic acid suggests a high degree of specificity in the patient's immune response to pipemidic acid.

Implications:

• This case highlights the importance of detailed drug history and careful rechallenge in diagnosing FDE.
• Understanding the specific triggers in FDE can aid in differentiating between drugs, especially those with similar chemical structures.
• Further research into the immunological mechanisms underlying pipemidic acid-induced FDE may inform safer antibiotic prescribing practices.